Benitec Biopharma Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2019 | $4.8M | $4.4M | $404.0K | $672.0K |
| FY2020 | $-7.5M | $-7.6M | $95.0K | $237.0K |
| FY2021 | $-12.8M | $-13.1M | $221.0K | $634.0K |
| FY2022 | $-15.9M | $-15.9M | $13.0K | $870.0K |
| FY2023 | $-18.0M | $-18.0M | $1.0K | $452.0K |
| FY2024 | $-19.4M | $-19.6M | $179.0K | $830.0K |
| FY2025 | $-23.6M | $-23.6M | $18.0K | $17.4M |
| FY2026 | $-16.5M | $-16.6M | $105.0K | $26.4M |